Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic cancer or other pancreatic disorders in the future.
PURPOSE: This clinical trial is collecting medical information and tissue samples from patients with pancreatic cancer or other pancreatic disorders.
Islet Cell Tumor
Other: medical chart review
Other: survey administration
Other: biospecimen collection
|Study Design:||Observational Model: Case-Only
Time Perspective: Prospective
|Official Title:||Biospecimen Resource for Pancreas Research, a Data & Tissue Bank (Also Known as a Bio-repository, Bio-bank, Data & Tissue Database, Data & Tissue Registry, Etc.) to Help Advance Research in Pancreas Disease|
- Collection of clinical data, health and family histories by survey [ Time Frame: baseline enrollment, 6 months, 12 months ] [ Designated as safety issue: No ]
- Collection of blood and/or tissue, fecal and oral specimens [ Time Frame: baseline ] [ Designated as safety issue: No ]
- Collection of information regarding food preparation and intake by survey [ Time Frame: baseline ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples With DNA
|Study Start Date:||October 2000|
|Estimated Study Completion Date:||September 2017|
|Estimated Primary Completion Date:||September 2017 (Final data collection date for primary outcome measure)|
Other: medical chart review
- To collect clinical data and family histories and blood and/or tissue samples from patients diagnosed with pancreatic diseases, including pancreatic cancer, for use in future studies.
- To collect information regarding food preparation and intake in these patients.
- To make available to researchers medical data and biospecimens to enable them to develop better ways to screen people at risk for pancreatic conditions, including pancreatic cancer.
- To investigate genes or substances that increase susceptibility of developing pancreatic conditions.
- To find agents that may help prevent, treat, or cure these conditions.
- To learn whether inherited factors increase the risk of pancreatic diseases, pancreatic cancer, or other cancers.
OUTLINE: This is a multicenter study.
Patients complete two 1-hour surveys assessing health, clinical and family history of pancreatic conditions including cancer, and food preparation and intake. Patients also complete a 15- to 30-minute follow up survey at 6 months and 1 year to assess health, health practices, and family history. A review of the patient's medical information is obtained from the medical record.
Blood samples are collected for future research studies. Oral cells and stool samples may also be collected for future studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00830557
|Contact: Sarah Amundsonemail@example.com|
|Contact: Bridget Eversmanfirstname.lastname@example.org|
|United States, Minnesota|
|Mayo Clinic Cancer Center||Recruiting|
|Rochester, Minnesota, United States, 55905|
|Contact: Clinical Trials Office - All Mayo Clinic Locations 507-538-7623|
|Principal Investigator:||Gloria M. Petersen, PhD, FACMG||Mayo Clinic|